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S-nitrosylation of proteins serves an important role in regulating diverse cellular processes
including signal transduction, DNA repair, and neurotransmission. Identification of S-
nitrosylation sites is crucial for understanding the significance of this post-translational
modification (PTM) in modulating the function of a protein. However, it is challenging to
identify S-nitrosylation sites directly by mass spectrometric (MS) methods due to the labile
nature of the S–NO bond. Here we describe a strategy for direct identification of protein
S-nitrosylation sites in an electrospray ionization (ESI) quadrupole time-of-flight (QTOF) mass
spectrometer without prior chemical derivatization of S-nitrosylated peptides. Both sample
buffer composition and MS hardware parameters were carefully adjusted to ensure that
S-nitrosylated peptide ions could be analyzed by the QTOF MS with optimal signal/noise
ratios. It was crucial that the proteins were preserved in a sample solution containing 1 mM
EDTA and 0.1 mM neocuproine at neutral pH. Proteins dissolved in this solution are amenable
to in-solution tryptic digestion, which is important for the analysis of biological samples.
S-nitrosylated peptides were effectively analyzed by LC/MS/MS on QTOF MS, with an
optimized cone voltage of 20 V and collision energy of 4 V. We have successfully applied this
method to thioredoxin, a key antioxidant protein, and identified within it an S-nitrosylation
site at Cys73. (J Am Soc Mass Spectrom 2008, 19, 1353–1360) © 2008 American Society for
Mass SpectrometryT he covalent modification of a cysteine sulfhy-dryl group with nitric oxide (NO) is called S-nitrosylation or S-nitrosation [1]. An increasing
number of proteins have been found to undergo S-
nitrosylation in vivo [2– 4]. For example, the inhibition
of protein-tyrosine phosphatases by S-nitrosylation is
critical in regulating cellular signal transduction path-
ways [5]; similarly, S-nitrosylation can suppress C-Jun
N-terminal kinase activation in intact cells [6]. On the
other hand, S-nitrosylation of OxyR has been shown to
activate OxyR-dependent transcriptional events [7],
while S-nitrosylation of ryanodine receptor promotes its
ability to release Ca2 from the sarcoplasmic reticulum
[8]. Therefore, S-nitrosylation functions as an important
regulatory mechanism for fine-tuning protein activities
within diverse cellular processes and biochemical path-
ways, including signal transduction, DNA repair, ion
channel regulation, and apoptosis [9-11]. Not all cys-
teines in a protein are equally susceptible to S-nitrosy-
lation; cysteine thiols with an acidic pKa appear to be
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mechanisms governing protein S-nitrosylation m a y also
include protein localization and protein–protein inter-
actions [13, 14]. Recent studies have also suggested that
S-nitrosylation may play key roles in regulating human
disease development. Abnormal increase of protein
S-nitrosylation events have been reported in patients
with diabetes, multiple sclerosis, tuberculosis, and
asthma [15]. Therefore, it is of great interest for biolo-
gists to identify protein S-nitrosylation sites and quan-
tify their dynamic status in an effort to determine how
S-nitrosylation and denitrosylation are regulated in
biological systems.
Several methods have been developed to detect
S-nitrosylated proteins. They include the use of a SNO-
specific antibody to detect in situ protein S-nitrosylation
by immunohistochemistry [16], and the use of a biotin-
switch method coupled with immunoblotting, 2D-gel
electrophoresis, or fluorescence gel electrophoresis to
detect changes in protein S-nitrosylation status under
different biological conditions [17–19]. However, none
of these methods identifies the specific S-nitrosylation
sites within the proteins. To this end, MS can be used
downstream of these methods. However, the labile
nature of NO attachment to the cysteine thiol presents
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fact that S-nitrosylated peptides are rarely observed in
MALDI-TOF MS spectra. Given the laser energies
needed for peptide protonation, NO usually falls off the
precursor ions in-source during ionization. Under gen-
tle ESI conditions, S-nitrosylated peptides have been
observed as a 29 Da ion (NO and H) over the
unmodified peptide ions for each S-nitrosylated cys-
teine [20]. In MS/MS analysis, the localization of the
S-nitrosylated cysteines in peptides containing more
than one cysteine is still problematic, given that S–NO
bonds are usually more easily fragmented than the
peptide backbone [21]. Recently, a biotin-switch
method coupled with MS identification of protein
S-nitrosylation sites was developed. In this method,
nitrocysteines in peptides are converted into the more
stable biotinylated cysteines, which can be analyzed by
MS/MS methods, either with MALDI or ESI techniques
[22, 23]. However, this method may produce some false
results stemming from the difficulties of precisely con-
trolling the multiple chemical reaction steps in the
biotin-switch protocol [24]. It is therefore desirable to
develop a method that can directly detect protein
S-nitrosylation sites without complicated derivatization
steps.
Published reports suggest that fine-tuning of MS in-
strument parameters may enable the determination of
peptide S-nitrosylation sites using ESI. Indeed, reports
demonstrating the identification of peptide S-nitrosylation
sites by LC/MS/MS have been published by Mirza
et al., using a Finnegan-MAT TSQ-700 triple quadru-
pole instrument [25]; by Taldone et al., using a Bruker
Daltonics Esquire 3000 quadrupole ion trap instrument
[26]; by Chen et al. using an ABI QSTAR-XL hybrid
QTOF instrument [12]; and by Hao et al., using an
Agilent Technologies MSD Ultra ion trap [27] and
Micromass Quattro II triple quadrupole instruments
[28]. Since each type of instrument is configured differ-
ently, MS parameters should be optimized for each
S-nitrosylation study. Here we describe a strategy for
the direct identification of protein S-nitrosylation sites
using a Waters Corp. (Milford, MA) QTOF mass spec-
trometer. The effectiveness of this strategy requires first,
careful adjustment of the buffer composition and pH to
minimize solution-phase denitrosylation, and second,
fine-tuning of both cone and collision energy voltages
for optimal ionization of S-nitrosylated peptides. This
may be achieved at the expense of reduced ionization
efficiency of non-nitrosylated peptides. We have suc-
cessfully utilized this method to identify a site on
thioredoxin that undergoes S-nitrosylation in vitro.
Experimental
Materials
All peptides including insulin B (9-23) (SHLVEALYL-
VCGERG, MH 1645.8, catalog no. 61,532), a -amyloid
peptide fragment (CFRHDSGY, MH 984.4, catalog no.61,979,), PKC  410 (GDTTSTFCGTPN MH 1200.5,
catalog no. 62,025), and caspase 3 (163-175) (CRGTELD-
CGIETD, MH 1411.6, catalog no. 60,792) were pur-
chased from AnaSpec (San Jose, CA). S-nitrosogluta-
thione (GSNO), neocuproine, and recombinant human
thioredoxin (Trx1) were purchased from Sigma (Cat.
No. T8690, St. Louis, MO). Acetonitrile (ACN) and
water were obtained from Mallinckrodt Baker (Phillips-
burg, NJ). Formic acid (FA) was purchased from EMD
Chemicals (Merck KGaA, Darmstadt, Germany). EDTA
solution (0.5 M, pH 8.0) was obtained from Cellgro
(Mediatech Inc., Herndon, VA). Sequencing-grade tryp-
sin was purchased from Promega (Madison, WI). All
other chemicals and reagents were purchased from
Sigma.
S-Nitrosylation of Synthetic Peptides and Trx1
One nmol of each peptide was mixed with a 10-fold
molar excess of GSNO in an aqueous solution contain-
ing 1 mM EDTA and 0.1 mM neocuproine (pH 6.8). The
reaction was carried out at 37 °C for 30 min in the dark.
The resulting peptide solutions were analyzed directly
on the QTOF MS. For the protein S-nitrosylation reac-
tion, 25 g of Trx1 was dissolved in 90 L of 10% ACN
containing 1 mM EDTA and 0.1 mM neocuproine (pH
6.8) and mixed with a 25-fold molar excess of GSNO.
The reaction was carried out at 37 °C for 30 min in the
dark, followed by acetone precipitation to remove ex-
cess GSNO. Ninety L of Trx1 was precipitated by
incubating samples with 360 L of cold acetone at
20 °C for 1 h. After 10 min centrifugation at 8000 g, the
supernatant was removed and the protein pellet was
resuspended in 30 L of 10% ACN containing 1 mM
EDTA and 0.1 mM neocuproine (pH 6.8). Then, 10 L of
this protein solution were directly infused into the
QTOF for MS analysis. The remaining 20 L of the
protein solution was mixed with an NH4HCO3 buffer
solution to a final concentration of 5 mM (pH 8.0). The
protein was digested by trypsin (at a trypsin:Trx1 ratio
of 1:5) at 37 °C overnight in the dark. The resulting
peptides were desalted via a PepClean C18 spin column
(Pierce, Rockford, IL) before LC/MS/MS analysis on
the QTOF MS.
Reversed-Phase Nano LC
Reversed-phase nano LC separation of Trx1 tryptic
peptides was carried out on an Ultimate 3000 nano LC
system (Dionex Corp., Sunnyvale, CA). The peptides
were first captured on a reversed-phase C18 trapping
column (0.3 mm  5 mm) and then resolved on a C18
capillary PepMap100 column (75 m  150 mm, 3 m,
100 Å, C18, Dionex) with a 65-min gradient of Solvent A
(2% ACN and 0.1% formic acid, FA) and Solvent B (98%
ACN and 0.1% FA): at 0 to 8.5 min, from 3% to 6% B; at
35 min, to 18% B; at 57 min, to 50% B, and at 65 min, to
95% B. The LC eluent was directly introduced into the
nano-ESI source, fitted with a PicoTip Emitter (New
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on the QTOF MS.
Mass Spectrometry
Peptide analyses were carried out on an API-US QTOF
tandem MS system equipped with a nano-ESI source
(Waters). The ESI capillary voltage was set at 3000 V.
Both cone and collision energy voltages were optimized
to achieve maximal ion intensities of the S-nitrosylated
peptide ions in the MS mode (see the Results and
Discussion section). The MS spectra (m/z 400–1900)
were acquired in the positive ion mode. For the syn-
thetic peptides, MS analyses were performed with di-
rect infusion. The MS/MS spectra of selected precursors
were acquired at a collision energy of 37 V. Argon was
used as the collision gas. For the peptides derived from
Trx1 tryptic digestion, LC/MS/MS analysis was per-
formed. The collision energy was set within a range of
17 to 55 V, depending on the charge states and the m/z
values. MS/MS spectra were acquired in data depen-
dent analysis mode, in which the top three most abun-
dant precursors with two to five charges from each MS
survey scan were selected for fragmentation.
Results and Discussion
Effects of pH and Metal Ion Chelators on
S-Nitrosylation
Due to the chemical instability of the S–NO bond, it is
crucial to optimize the buffer composition for direct
identification of peptide S-nitrosylation sites using the
ESI-QTOF MS approach. Two peptides, -amyloid pep-
tide and insulin B (9-23) were incubated with 10-fold
molar excess of GSNO in different sample solutions
(Table 1). The MS spectra of the resulting peptides were
acquired on a QTOFMS via direct infusion. The relative
percentages of S-nitrosylated peptides among all vari-
ants of the same peptide in the MS spectra are plotted in
Figure 1. Under experimental conditions I and II, both
sample solutions contained 1 mM EDTA and 0.1 mM
neocuproine (a copper chelator) at pH 6.8. However, the
pH of the sample solution was adjusted to 3.0 by adding
FA before infusion analysis on the QTOF MS under
condition II, while the peptides were analyzed without
pH adjustments in condition I. Three major peptide
fractions were observed in the MS spectra of both
Table 1. Peptide S-nitrosylation conditions tested
Experiment S-nitrosylation reaction solution
I 1 mM EDTA and 0.1 mM neocuproine, (pH
II 1 mM EDTA and 0.1 mM neocuproine, (pH
III H2O, (pH 6.8)
IV 1 mM EDTA, 0.1 mM neocuproine and 0.1%
acid, (pH 3.0)peptides: unmodified, S-nitrosylated, and glutathio-lated, distributed among different charge states. The
relative percentages of S-nitrosylated peptide ions un-
der experimental conditions I and II were 53% and 55%
for -amyloid peptide, and 40% and 42% for insulin
B (9-23), respectively (Figure 1). These surprising results
indicated that acidification from pH 6.8 to pH 3.0 after
the S-nitrosylation reaction had little effect on the
relative percentages of S-nitrosylated peptide ions ob-
served in MS. By contrast, under experimental condi-
tion IV, in which both S-nitrosylation and ESI solutions
were maintained at pH 3.0, the relative percentages of
S-nitrosylated peptides were dramatically decreased to
less than 5% (Figure 1), indicating that the peptide
S-nitrosylation efficiency was reduced in the acidic
environment. Since thiol S-nitrosylation reactivity de-
pends on its pKa, acidic pH decreases thiolate nucleo-
philicity, which may in turn reduce the yield of
S-nitrosylated peptides.
EDTA and neocuproine were used as chelating
agents to sequester metal ions during S-nitrosylation
MS analysis solution
1 mM EDTA and 0.1 mM neocuproine, (pH 6.8)
1 mM EDTA, 0.1 mM neocuproine and 0.1% formic
acid, (pH 3.0)
H2O, (pH 6.8)
ic 1 mM EDTA, 0.1 mM neocuproine and 0.1% formic
acid, (pH 3.0)
Figure 1. Effects of pH and metal chelators on MS sensitivities
for detecting S-nitrosylated peptide ions. One nmol of synthetic
peptides -amyloid peptide and insulin B (9-23) were treated with
tenfold molar excess of GSNO and analyzed on a QTOF MS under
the different experimental conditions outlined in Table 1. Relative
percentages of the S-nitrosylated peptide ion signals were calcu-
lated as the percentage ion intensities of the S-nitrosylated peptide
divided by the sum of the ion intensities of all peptide species
(peptide  peptide-GS  peptide-NO) derived from the same
precursor. The MaxEnt3 module in the MassLynx software was
used to convert all ion charge states into centroid singly-charged6.8)
6.8)
formions before the calculations.
1356 WANG ET AL. J Am Soc Mass Spectrom 2008, 19, 1353–1360reactions. It has been reported that S–NO is highly
sensitive to the presence of copper ions; even low
concentrations induce S–NO decomposition [29]. S–NO
bond breakage can be inhibited by the copper chelator
neocuproine [29]. We confirmed the stabilizing effects
of metal ion chelators on S–NO bonds, observing that
the relative percentages of S-nitrosylated peptides were
dramatically decreased in the absence of EDTA and
neocuproine (Figure 1, conditions I and III).
Optimization of QTOF MS Parameters for Direct
Analysis of S-Nitrosylated Peptides
To obtain maximal ion signals for S-nitrosylated pep-
tides, several QTOF MS instrument parameters were
evaluated; among these, changes in cone and collision
energy voltages had the most dramatic effects. In gen-
eral, most ion intensities increased with the elevation
of the cone voltages from 15 to 30 V, except that
S-nitrosylated peptide ion intensities decreased once
the cone voltages exceeded 20 V (Figure 2a). It is well
known that the S–NO bond is fragile. For example, we
found that the S–NO bonds were easily cleaved by the
MALDI process. No S-nitrosylated peptide MS signal
Figure 2. Effects of QTOF MS cone and collision energy voltages
on MS ion intensities of S-nitrosylated peptides. (a) With the
collision energy set at 4 V, the effects of varied cone voltages on
S-nitrosylated peptide ion signals were analyzed. (b) With the
cone voltage set at 20 V, the effects of varied collision energy
voltages were evaluated. The ion intensities were calculated using
the MaxEnt3 module in the MassLynx software.for the synthetic peptides used in this study could beobserved in a ABI 4800 MALDI-TOF/TOF MS (data not
shown). Although ESI is a softer ionization method,
when the cone voltage was too high, the labile S–NO
bond was easily fragmented during ion transmission.
The effects of increasing cone voltages on S-nitrosylated
peptides ion stability may also be dependent upon the
peptide sequence and the position(s) of the nitrocys-
teine(s). Therefore the optimal cone voltage for any
given peptide may need to be determined empirically.
However, the recommended 20 V setting reported here
appeared to be optimal for two additional peptides
(Supplemental Figure 1, which can be found in the
electronic version of this article), suggesting that this
condition is effective for analyzing S-nitrosylated pep-
tides in Waters QTOF MS. Consequently, a cone volt-
age value of 20 V was deemed optimal for studying
S-nitrosylated peptides on the QTOF MS.
In the Waters MassLynx software, the cone voltage
readback value in the tune page is the sum of cone,
collision energy, extractor, and RF lens voltages. Since
the extractor and RF lens voltages made relatively small
contributions to the readback value, the optimization of
the collision energy became important for sensitive
detection of S-nitrosylated peptide ions. As shown in
Figure 2b, when the collision energy was increased
from 0 to 4 V, the ion intensities for S-nitrosylated
peptides were significantly enhanced. Further increase
of the collision energy resulted in the reduction of the ion
intensities for S-nitrosylated peptides. Thus, the optimal
collision energy for the analysis of S-nitrosylated peptides
on the QTOF was set at 4 V.
The optimal cone voltage and collision energy deter-
mined in this study apply only to Waters QTOF instru-
ments. For other instruments, the optimal parameters
for analyzing S-nitrosylated peptides may vary due to
the differences in hardware configuration and software
design. In general, to preserve S-nitrosylated peptide
ion stability, both cone and collision energy voltages
should be set at much lower values than those used for
conventional peptide detections. Typically, the optimal
cone voltage for detecting S-nitrosylated and non-
nitrosylated peptides in our Waters QTOF MS is 20 and
37 V, respectively. Similarly, the collision energy for
analyzing S-nitrosylated peptide ions on QTOF MS is 4
V compared with 8 V for non-nitrosylated ions. Similar
degrees of differences may apply to quadrupole time-
of-flight instruments from other vendors. Obviously,
the optimal conditions have to be determined under
specific experimental conditions.
Identification of S-Nitrosylation Sites in
Model Peptides
The peptides were S-nitrosylated using GSNO under
the optimized experimental condition II described
above. The MS spectrum for insulin B (9-23) was
acquired with a cone voltage of 20 V and collision
energy voltage of 4 V. Before S-nitrosylation, doubly-
/z 8
sylat
ion e
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predominantly observed (Figure 3a). After the S-
Figure 3. MS and MS/MS analysis of S-nitrosy
of unmodified peptide. Triply- (m/z 549.25), do
ions were observed. (b) MS spectrum of the pep
doubly- (m/z 837.90), and singly-charged (m/z 1
(M  NO) were observed, while the triply-
corresponding to S-glutathiolated peptide (M 
doubly-charged S-nitrosylated peptide ion of m
Cys19. All the y-series ions containing the S-nitro
29 Da. The cone voltage was 20 V and the collisnitrosylation reaction, the resulting singly- (m/z1674.81), doubly- (m/z 837.90), and triply-charged (m/z
558.93) S-nitrosylated peptide ions were observed (Fig-
insulin B (9-23) on QTOF MS. (a) MS spectrum
(m/z 823.38), and singly-charged (m/z 1645.75)
after GSNO treatment. The triply- (m/z 558.93),
1) ions corresponding to S-nitrosylated peptide
651.28) and doubly-charged (m/z 976.44) ions
were also detected. (c) MS/MS spectrum of the
37.90. The S-nitrosylation site was located on
ed cysteine were found to have a neutral loss of
nergy was 37 V for the MS/MS analyses.lated
ubly-
tide
674.8
(m/z
SG)ure 3b), indicating the formation of S-nitrosylated insu-
1358 WANG ET AL. J Am Soc Mass Spectrom 2008, 19, 1353–1360lin B (9-23). Besides S-nitrosylated peptides, we also
detected the doubly- (m/z 976.44) and triply-charged
(m/z 651.28) ions corresponding to S-glutathiolated in-
sulin B (9-23), which was an alternative reaction prod-
uct of the GSNO treatment (Figure 3b). After converting
all the ion charge states into singly-charged species with
the MaxEnt3 module in the MassLynx software, we
found that 40% of insulin B (9-23) peptides were
S-nitrosylated, 26% were S-glutathiolated, and 34%
were unmodified. We then performed an MS/MS anal-
ysis of the doubly-charged S-nitrosylated insulin B
(9-23) ion (m/z 837.90) at a collision energy of 37 V.
Using this high collision energy, the S–NO bond was
fragmented before fragmentation of the peptide back-
bone, resulting in the neutral loss of 29 Da in many
y-series ions. The S-nitrosylation of Cys19 was clearly
identified in the MS/MS spectrum (Figure 3c). Similar
neutral loss of NO was also observed in the MS/MS
spectrum of an amyloid peptide (Supplemental Figure 2).
Identification of an S-Nitrosylation Site
in Thioredoxin
Trypsin digestion is usually performed in preparing
peptides for MS analysis. To determine (1) whether the
digestion buffer affects protein S-nitrosylation status,
and (2) whether trypsin activity is inhibited by the
metal chelators present in the S-nitrosylation solution,
we digested the S-nitrosylated insulin B (9-23) peptide
with trypsin at 37 °C overnight in the dark. From QTOF
MS analysis, both triply- (m/z 539.99) and doubly-
charged (m/z 809.48) ions corresponding to the tryptic
fragment SHLVEALYLCNOGER were observed (Figure
4a). It appeared that the S–NO bond was stable follow-
ing tryptic digestion. As only about 60% of the S-
nitrosylated peptide was digested (Figure 4a), the pro-
teolytic activity of trypsin was likely reduced by the
metal chelators in the S-nitrosylation buffer; it is known
that Ca2 is important for maintaining trypsin activity.
Consequently, for biological protein extraction and
preparation, metal chelators should be included to
preserve protein S-nitrosylation status; however, higher
trypsin-to-protein ratios may be needed to ensure effi-
cient protein digestion.
Thioredoxin-1 (Trx1) is a 12-kDa multifunctional
protein involved in cell growth, death, protein reduc-
tion, and tissue development [30]. It has two cysteines
located in its catalytic center, and it functions as a redox
regulator in cells [31, 32]. Earlier studies have reported
that human Trx1 is readily S-nitrosylated both in vitro
and in vivo, and the NO group in S-nitrosylated Trx1
can be transferred to other proteins, such as caspase-3
(at Cys163) [33] via a process called trans-nitrosylation.
We used a 25-fold molar excess of GSNO to S-nitrosylate
recombinant human Trx1. One-third of the resulting
protein solution was directly infused into the QTOF for
MS analysis. The MaxEnt1 module in the MassLynx
software was used to deconvolute the rawMS spectrumto obtain the molecular weight of the S-nitrosylated
Trx1. After the S-nitrosylation reaction, 66% of Trx1 was
found to contain one additional NO group (29 Da), at a
mass of 13,794.40 Da, compared with the unmodified
Trx1, at a mass of 13,765.15 Da. In addition, we also
observed that 17% of Trx1 contained two NO groups
(13,823.35 Da) (Figure 4b). To identify the S-nitrosylation
sites, Trx1 was digested and the resulting peptides were
analyzed by LC/MS/MS. Since the Trx1 catalytic do-
main sequence is homologous to bovine pancreatic
trypsin inhibitor, Trx1 may be able to inhibit trypsin
activity [34]. Indeed, during the digestion, we had to
increase the trypsin:Trx1 M ratio to 1:5 to achieve a
thorough digestion of Trx1. There are five cysteines in
human Trx1; all cysteine-containing peptides were ob-
served in our LC/MS/MS analysis. A doubly-charged
ion (m/z 597.26) corresponding to 73CMPTFQFFK81 with
methionine oxidized was found to be substantially
S-nitrosylated at Cys73 (Figure 4c). We also detected a
doubly-charged ion (m/z 811.89) corresponding to 22LV-
VVDFSATWCGPCK36 with the Trx1 active site disul-
fide bond formed between Cys32 and Cys35 (Supple-
mental Figure 3A). In addition, a triply-charged ion (m/z
906.72) corresponding to 49YSNVIFLEVDVDDCQD-
VASECEVK72 with both Cys62 and Cys69 in the re-
duced states was also observed (Supplemental Figure
3B). We did not find detectable amounts of S-nitrosy-
lated peptides containing Cys62 and Cys69 in this
study, although Cys69 has been previously reported to
be S-nitrosylated [4, 30]. This discrepancy might be due
to the different in vitro S-nitrosylation conditions used,
including different GSNO concentrations and the dura-
tion of the reaction. At higher concentrations of GSNO
or longer incubation times, we observed Trx1 with up to
three NO groups added (data not shown). Mitchell and
Marletta reported that Cys73 was S-nitrosylated after
GSNO treatment [33]. Based on the crystal structure of
Trx1, Cys73 is the most surface-accessible of Trx1 cys-
teines, and is located close to the N-terminus of the
protein, whereas Cys69 is only minimally exposed [33].
These results corroborate the findings reported by
Mitchell and Marletta [33]. In this study, 66% of Trx1
was found to contain one NO modification and 17%
contained two NO group additions. We could only find
one tryptic peptide containing S-nitrosylated Cys73.
Our inability to detect the second S-nitrosylation site
may be due to the substantially lowered concentrations
of the peptide(s) containing the second S-nitrosylation
site; alternatively this S-nitrosylated peptide may be too
hydrophilic and was lost during the desalting steps
before LC/MS analysis.
Summary
We developed an effective LC/MS/MS strategy that
enables us to directly identify S-nitrosylation sites in
proteins using ESI-QTOF MS. Considering the labile
nature of the S–NO bond, the sample solution should
include both EDTA and neocuproine, and be main-
1359J Am Soc Mass Spectrom 2008, 19, 1353–1360 IDENTIFICATION OF S-NITROSYLATION SITES BY QTOFFigure 4. Identification of Trx1 S-nitrosylation site. (a) Evaluation of tryptic digestion conditions on
S-nitrosylation. One nmol of insulin B (9-23) peptide was nitrosylated by GSNO. The resulting peptide
solution was mixed with an NH4HCO3 buffer solution to a final concentration of 5 mM (pH 8.0) and
digested by trypsin (at a trypsin: peptide ratio of 1:50) at 37 °C overnight in the dark, followed by MS
analysis on QTOF MS. The triply- (m/z 539.99) and doubly-charged (m/z 809.48) ions corresponding to
the S-nitrosylated tryptic peptide fragment SHLVEALYLCGER were observed. Tryptic digestion was
incomplete, as a substantial amount of undigested and S-nitrosylated insulin B (9-23) (m/z 559.00 and
m/z 838.01) was also observed. (b) The deconvoluted spectrum of S-nitrosylated Trx1 protein after
GSNO treatment. The unmodified (13,765.15 Da), singly- (13,794.40 Da) and doubly-S-nitrosylated
(13,823.35) Trx1 species were observed. (c) MS and MS/MS spectra of a S-nitrosylated tryptic Trx1
peptide. The doubly-charged ion (m/z 597.26, see insert) in the MS spectrum corresponded to
S-nitrosylated 73CMPTFQFFK81, with methionine oxidized. In the MS/MS spectrum, both y-series and
b-series ions confirmed the peptide sequence as CMPTFQFFK, with its S-nitrosylation site located at
Cys73.
1360 WANG ET AL. J Am Soc Mass Spectrom 2008, 19, 1353–1360tained at neutral pH to prevent protein denitrosylation
during protein extraction, digestion, and analysis. Both
cone and collision energy voltages in QTOF MS should
also be fine-tuned to preserve the S–NO bonds. Using
this method, we found that Cys73 in human Trx1 was
specifically S-nitrosylated by GSNO treatment. A simi-
lar approach could be adapted for the identification of
S-nitrosylation sites in biological samples.
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